Company intelligence / Profile preview

Todd Pharm

Seodaemun-gu, Seoul, South Koreatodd-pharm.com ↗
Ownership
Private
Development stage
Other
01

Overview

TODD Pharm is a South Korean biotechnology company specializing in the structure-based design and development of protein-based and synthetic chemical therapeutics. A subsidiary of Ewha Technology Holdings, the company focuses on metabolic diseases, such as obesity and metabolic dysfunction-associated steatohepatitis (MASH), as well as multi-drug resistant bacterial infections. Its lead program, TODD-B-001, is a patented, high-affinity FGF21 variant designed for enhanced potency and thermostability, currently in preclinical development for MASH and obesity. Additionally, TODD Pharm is developing TODD-C-001, a novel beta-lactamase inhibitor aimed at overcoming antibiotic resistance in multi-drug resistant pathogens.

Therapeutic areas
Infectious DiseasesEndocrinologyMetabolic DisordersGastroenterology
Modalities
Recombinant proteinBiologicSmall molecule
Industry
Biotech
02

Drug pipeline

1 asset

FGF21-M5

Preclinical
03

Partnerships

WithpetbioRimmunologyParmir therapeuticsPusan National University

Beyond the preview

Go deeper on Todd Pharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Todd Pharm.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call